2 / 27
Page 56
Notes:
allied
academies
J Pharmacol Ther Res 2017 Volume 1 Issue 2
November 02-03, 2017 Chicago, USA
4
th
International Congress on
International Conference and Exhibition on
Drug Discovery, Designing and Development
Biochemistry, Molecular Biology: R&D
&
Present and future collaborative drug discovery informatics innovations
Luke S Fisher
Collaborative Drug Discovery, USA
C
DD’s unique IT architecture (true multi-tenant) allows
for distinctive use cases compared to traditional (single
tenant, virtualized) drug discovery informatics platforms.
CDD’s architectural principles and the application of modern
engineering methodologies enable CDD to democratize
traditionally expert informatics tools so that all scientists can
benefit. CDD Vault was created from scratch to work with the
cloud. As a natural consequence, CDD Vault’s architecture
and features accommodate those modern requirements. We
will explain how the benefits of modern cloud IT principles
can propel science forward.
Speaker Biography
Luke’s background brings twenty years of experience in scientific informatics solutions.
Managing Pre-Sales, Post-Sales and working in Account Management has expanded his
domain knowledge of scientific informatics and provided him the ability to maintain
a successful track record. Luke serves leading pharmaceutical, biotech, agricultural,
chemicals, academic and government labs. Luke has experience in scientific software
solutions from the smaller scale deployment of point solutions like molecular modeling
packages to the larger enterprise scale of ELNs, scientific workflow technologies,
data content, analysis and visualization. His background also includes managing the
support complexity of software integration strategies based on numerous mergers and
acquisitions.
e:
luke@collaborativedrug.com